Identification of undiagnosed inflammatory arthritis in a community health fair screen.
Identification of undiagnosed inflammatory arthritis in a community health fair screen.
复制标题
DOI:
10.1002/art.24834
复制
发表时间:
2009-12-15
影响因子:
--
通讯作者:
Holers, V. Michael
中科院分区:
文献类型:
--
作者:
Deane, Kevin D.;Striebich, Christopher C.;Goldstein, Barbara L.;Derber, Lezlie A.;Parish, Mark C.;Feser, Marie L.;Hamburger, Elaine M.;Brake, Stacey;Belz, Cindy;Goddard, James;Norris, Jill M.;Karlson, Elizabeth W.;Holers, V. Michael
The primary goals of this study were: 1) to identify individuals with undiagnosed inflammatory arthritis (IA) and rheumatoid arthritis (RA) in a community health-fair screen, and 2) to establish in a health-fair setting the diagnostic accuracy of combinations of the Connective Tissue Disease Screening Questionnaire (CSQ) and autoantibody testing for IA. Screening for IA/RA was performed at health-fair sites using a combination of CSQ, joint examination, rheumatoid factor (RF) and anti-cyclic citrullinated (anti-CCP) antibody testing. IA was defined as ≥1 swollen joint/s suggestive of synovitis on joint examination by a trained clinician. Six-hundred one subjects were screened; 51.0% participating because of joint symptoms (pain, stiffness, or swelling). Eighty-four subjects (14.0%) had ≥1 swollen joint/s designated as IA on joint examination. Of the 601 subjects screened, 9 (1.5%) had IA and met ≥4 of 7 American College of Rheumatology criteria for RA but had no prior diagnosis of RA, and 15 (2.5%) had IA and RF and/or anti-CCP positivity, suggesting early RA. The diagnostic accuracy of combinations of CSQ and autoantibody testing for the identification of IA yielded maximal sensitivity, specificity, positive and negative predictive values of 95.3%, 99.2%, 71.4%, and 97.7%, respectively. Health-fair screening may be an effective approach for the identification of individuals with undiagnosed IA/RA. A combination of CSQ and autoantibody testing alone has clinically useful diagnostic accuracy for the detection of IA. Decisions regarding which methodology to use for future health-fair IA/RA screening will depend on goals of screening and funding.
登录
查看更多内容
影响因子:
--
作者:
Goekoop-Ruiterman, YPM;de Vries-Bouwstra, JK;Dijkmans, C
通讯作者:
Dijkmans, C
影响因子:
2.3
作者:
Cush, JJ
通讯作者:
Cush, JJ
影响因子:
37.8
作者:
Alberti, K. G. M. M.;Eckel, Robert H.;Smith, Sidney C., Jr.
通讯作者:
Smith, Sidney C., Jr.
影响因子:
1.9
作者:
LANDIS, JR;KOCH, GG
通讯作者:
KOCH, GG
影响因子:
27.4
作者:
Gabriel, S. E.
通讯作者:
Gabriel, S. E.